Evidence map›Paper›PMID 40601415›Full record

ReviewACS nano2025

Carbon Dots as an Emergent Class of Sustainable Antifungal Agents.

Mattia Ghirardello, Javier Ramos-Soriano, M Carmen Galan

Abstract readReview
In one paragraph

Review in ACS nano, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review of Antimicrobial Properties of Carbon Nanomaterials.International journal of molecular sciences · 2026
    Review
  5. Advances in the Control of Plant Fungal Pathogens.Journal of fungi (Basel, Switzerland) · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mattia GhirardelloDepartment of Chemistry and Instituto de Investigación en Química de la Universidad de La Rioja (IQUR), Universidad de La Rioja, Logroño 26006, Spain.ORCID 0000-0002-2855-4801
Javier Ramos-SorianoInstituto de Investigaciones Químicas (IIQ), CSIC - Universidad de Sevilla, Av. Américo Vespucio 49, Seville 41092, Spain.ORCID 0000-0002-3054-0679
M Carmen GalanSchool of Chemistry, University of Bristol, Cantock's Close BS8 1TS, United Kingdom.ORCID 0000-0001-7307-2871

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbon-based functional nanomaterials with distinct photoluminescent properties have gained significant attention for their diverse applications in bioimaging, biomedicine, and antimicrobial treatments. Among these, carbon dots (CDs) have emerged as promising fluorescent nanomaterials due to their inherent photoluminescence properties, high stability, water solubility, ease of functionalization, biocompatibility, and low synthetic cost. Many strategies have been developed for their synthesis, utilizing a myriad of carbon precursors from small molecules to bulk or waste materials, which influence their structural and photoluminescent properties. Their fluorescence emission and functionality can be tuned through heteroatom doping, surface modifications, and reaction conditions, making them highly tunable nanomaterials suitable for applications in sensing, catalysis, anticancer and antimicrobial treatments, and biomedical imaging. This review explores various types of synthesized CDs, their structural features, and their applications in fungal bioimaging, antifungal therapies, and protective food packaging to demonstrate their potential in combating fungal resistance and contamination challenges.

Indexed as

Antifungal AgentsCarbonQuantum DotsAnimalsFungiHumansAntifungal AgentsCarbonantifungalbioimaging probescarbon dot compositescarbon dot nanomaterialsdiagnosticsfluorescent probesnanomaterialstheranostics

Identifiers

PMID40601415
PMCPMC12269365

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.